Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain.
Shcherbatko, A., Rossi, A., Foletti, D., Zhu, G., Bogin, O., Galindo Casas, M., Rickert, M., Hasa-Moreno, A., Bartsevich, V., Crameri, A., Steiner, A.R., Henningsen, R., Gill, A., Pons, J., Shelton, D.L., Rajpal, A., Strop, P.(2016) J.Biol.Chem. 291: 13974-13986
- PubMed: 27129258 
- DOI: 10.1074/jbc.M116.725978
- PubMed Abstract: 
The prominent role of voltage-gated sodium channel 1.7 (Nav1.7) in nociception was revealed by remarkable human clinical and genetic evidence. Development of potent and subtype-selective inhibitors of this ion channel is crucial for obtaining therape ...